Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
23 participants
INTERVENTIONAL
2019-05-01
2021-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Its effect was compared to an active placebo treatment
* An improvement in tinnitus distress was found after use of broadband amplification
* No effect was found on the tinnitus loudness
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Amplification and Tinnitus Masker Performance and Benefit for Adults With Hearing Loss and Tinnitus
NCT07298499
Efficacy of Amplification With Hearing Aids for Tinnitus Relief
NCT03716544
Evaluation of the Clinical Benefit of the Hearing Aids Tinnitus Feature.
NCT05292534
Auditory-somatosensory Stimulation to Alleviate Tinnitus
NCT02974543
Treatment of Tinnitus With Noninvasive Neuromodulation and Listening Therapy
NCT04934371
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Broadband amplification
broadband amplification: (125 Hz to 10 kHz)
Broadband amplification from hearing aids
Amplification from 125 Hz to 10 kHz
Band-limited amplification
band-limited amplification (125 Hz to 3-4 kHz)
Band-limited amplification from hearing aids
Amplification from 25 Hz to 3-4 kHz
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Broadband amplification from hearing aids
Amplification from 125 Hz to 10 kHz
Band-limited amplification from hearing aids
Amplification from 25 Hz to 3-4 kHz
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* hearing thresholds (\<=25 dB HL) up to 2000 Hz and hearing loss at frequencies above 2 kHz
* inexperienced hearing aid user
Exclusion Criteria
* Ménière's disease, otosclerosis, stapedectomy, stapedotomy or tympanoplasty
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Technical University of Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mie Joergensen
PhD student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mie Jørgensen
Role: PRINCIPAL_INVESTIGATOR
Technical University of Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Technical University of Denmark
Kongens Lyngby, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
766041
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.